chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Significant central tongue numbness/tingling - on scale of 1-10 symptom onset was #8 - this lasted for at least 2 hours at this level and then over the next 4-5 hours the symptom slowly diminished and resolved by 8pm.   Woke 12/5/09 approximately 9:15 am without noting any symptoms then around 10:00 am noted low level central tongue and roof of mouth numbness which over the course of approximately an hour advanced to upper lip and bridge, tip and nostrils of nose
About a week after vaccination I developed a sudden onset of small cherry angiomas on my face, scalp, and trunk of my body.. I have never had them, not even one, in my entire life. No one else in my family has had them, even in old age. After going to a dermatology appt she recommended that I submit a report because it seemed to be an under reported reaction.  They are harmless, but it's a reported side effect and likely under reported - so I'm filing the report as suggested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication were not provided. It was alleged that the patient was inoculated with a dose of ZOSTAVAX vaccine (dose, route, lot # and expiration date were not provided) on or about 11-NOV-2014 at a hospital, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 20-NOV-2014, the patient was treated at a hospital for a painful rash and complications that were diagnosed as shingles and acute retinal necrosis attributable to VZV. The patient was hospitalized for a period of seven days for these conditions and was prescribed acyclovir to manage her symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Upon internal review, acute retinal necrosis was determined to be medically significant. Additional information has been requested.
Information has been received from a registered nurse concerning a 18 year old Caucasian female who on 9/17/92 and 8/12/97 was vaccinated with the first and second dose of MMR II, respectively. On 6/2/00 a rubella IgG tet was performed and results showed that the "antibody levels were in the quivocal range for this assay may be insufficient to protect against clinical illness upon exposure to rubella virus." The pt sought unspecified medical attention. It was noted that on 7/11/01 the pt received a third dose  (lot 634420/0012L), subcutaneously. Additional info has been requested.
Pt developed vesicular pruritic rash (on 8/10) with varicella vaccine on 07/21/03. Seen on 8/12 with topical lesions.
Chickenpox; This spontaneous report has been received from a physician and refers to a 13-year-old male patient. The patient's concurrent condition, medical history, concomitant therapies, historical drug or allergies were not provided.   On 30-JUN-2008, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot #, expiration date, dose and anatomical location of vaccine were not reported) reconstituted with 0.5 mL of sterile diluent, administrated via subcutaneous for vaccination. On an unspecified date in, after 2 doses of varicella virus vaccine live (oka/merck)(VARIVAX), the patient had recently developed chickenpox. At the reporting time, the patient had not recovered from chickenpox.  The causality assessment between chickenpox and varicella virus vaccine live (oka/merck)(VARIVAX) was not reported.
chills; pain at the injection site; This is a spontaneous report from a contactable consumer, the patient. A female patient  received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 17Dec2020  in the as a single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported.  On Dec2020 the patient experienced chills and pain at the injection site. The clinical outcome of the chills and pain at injection site was unknown.   Information regarding lot number has been requested.
Red, swelling around injection site a few days after injection had been administered but went away after 3 or 4 days. It was not painful.
Pulled muscle; Even hurts to take a deep breath; I startedhaving a pain from the right side of myneck; startedhaving a pain from the right side of myneck, down over and around myshoulder blade; startedhaving a pain from the right side of myneck, down over and around myshoulder blade to mid-back.; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734) via an unspecified route of administration in the arm left on 30Mar2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included chronic neck issues, osteoarthritis and kiwi fruit allergy, left shoulder bursitis from an unspecified date.  The patient received other medications in two weeks which included cetirizine hydrochloride (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), enzymes (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received steroid (MANAFACTURER UNKNOWN) on an unspecified date for shoulder bursitis. Had a steroid shot several weeks ago for bursitis in left shoulder. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 11:45 the patient experienced a pain from the right side of neck, down over and around shoulder blade to mid-back. It feels like a pulled muscle. It had progressively gotten worse over the past three days since the vaccine. It even hurt to take a deep breath. The patient stated that it may be neurological, and if it gets much worse, she'll need to go to the doctor. She was not positive this was related to the vaccine, but it was very coincidental if it was not. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pulled muscle, abnormal breathing, neck pain, shoulder blade pain, back pain was not recovered at the time of reporting.   No follow-up attempts are needed; No further information is expected.
On night of vaccine developed pain, swelling, redness, chills. Progressed for 2-3 days. Has decreased in swelling and pain. No SOB, no wheezing. Exam with mouth induration 30 x 20 mm. Temp 98.6 BO 114/70. Tx VISTARIL 25mg TID.
Fever 102 1 day post vaccination.  Rash developed 2 days post vaccination started on head and progressed distally down body. Parent adminsitered Tylenol and fever resolved as of second day post vaccination. Rash still present at time of call from parent 2nd day post vaccination.
12 mins post vaccination pt had a sudden onset of the sensation of the inability to move his jaw and anxiety.  Pt reported feeling suffocated. Vitals: 9:29 133/74, 89, 18, 100% -- > 9:40 126/91, 80, 18, 100% Patient stable and released from the vaccination site @9:45.  pt transported via wheelchair to exit.
POOR QUALITY PRODUCT ADMINISTERED; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned an adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A expiry: 11-APR-2022) dose was not reported, administered on 10-DEC-2021 13:25 for prophylactic vaccination. No concomitant medications were reported. On 10-DEC-2021, the patient experienced poor quality product administered. On 10-DEC-2021, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the poor quality product administered and incorrect product storage was not reported. This report was non-serious.
The day of vaccine at night I began to feel pain in my right thigh. The following day pain was in my entire left leg and had a massive headache. My lips began to crack from dryness and a burning sensation started the next day all over my body, specifically my abdomen and legs. All side effects as of today have subsided except the burning and tingling has continued for a month now all over my body. It comes and goes in waves but has not resolved. My doctors don?t know what to do about it. Lab work is being run but if it comes back normal I am being told I need to see a neurologist if these neurological side effects continue.
This spontaneous report has been received from a physician on 08-JAN-2015 refers to a 10 month old female patient. The patient had no pertinent medical history, drug reaction/allergies or concomitant medication. The patient was vaccinated with three doses of RECOMBIVAX HB on 13-AUG-1992 (at 5 months old), 15-JAN-1993 (at 10 months old) and 15-NOV-1993 (at 20 months old), respectively. On an unspecified date in April 2014 the 22 year old patient developed inflammatory bowel disease. No treatment for the inflammatory bowel disease was reported. On 31-MAY-2014, the result of a "hepatitis B titer" drawn was "6" (unit not provided). As treatment for the "low titer of 6" the patient was administered two additional doses of RECOMBIVAX HB (Lot # 1572AA, expiration date 26-MAY-2014) on 06-JUN-2014 and 08-JUL-2014 which had expired. At the time of the report, the outcome of the events was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccinated 12/13/2021, 4/23/2021, 3/26/2021. Hospitalized with COVID 1/8/22
At 12:05PM client states he started to feel dizzy and nauseated. O2 was given via facemask at 2L while being fanned. Vitals where taken and are as follows BP:97/48, BPM:55 and O2:99. Client was given sugar in a form of a cracker and also requested to have a sip of water. After fifteen minuets client states he  felt well and wanted O2 taken off. Client was also help off examination table to bench. Client had a good gait and was able to walk by himself. After five minutes of being on bench last set of vitals where taken and are as follows BP:130/86, BPM:93 and O2:97. Client left clinic without any s/s of distress.
First shot was very bad/ not as bad; Arm really red; Arm swollen; Arm hot; Aches, pains; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of erythema (1st dose received on an unknown date, refer case US2022AMR120491).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad, erythema of extremities, swelling arm, extremities hot feeling of and pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the feeling bad, erythema of extremities, swelling arm, extremities hot feeling of and pain were unknown.   It was unknown if the reporter considered the feeling bad, erythema of extremities, swelling arm, extremities hot feeling of and pain to be related to Shingles vaccine.  Linked case(s) involving the same patient:US2022AMR120491   Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient stated that, his/her Shingles shot was not as bad. The patient's arm really red, swollen and hot. The patient also experienced aches and pains. Additional supportive information: The follow-up would not possible, as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR120491:Same reporter
Starting about an hour after the 2nd dose was administered she began experiencing severe nausea and vomiting, increased BP 133/77, pulse 110, temp 98.8 F. Symptoms resolved over several hours.
Information has been received from a consumer concerning her 11 year old daughter with no medical history and no drug allergies, who on 28-JAN-2008 was vaccinated with a first dose of Gardasil along with VARIVAX (MSD), hepatitis A virus vaccine (unspecified) (manufacturer unknown), meningococcal vaccine (unspecified), and DTaP.  Other concomitant therapy included quetiapine funarate (SEROQUEL), oxcarbazepine (TRILEPTAL), and unspecified growth hormone.  On 05-FEB-2008, eight days later, the patient experienced nausea, dizziness, headaches and changes in vision.  The patient was taken to the emergency room because of the dizziness but was not admitted to the hospital.  No laboratory diagnostics were performed.  At the time of the report, the patient was recovering.  No product quality complaint was involved.  Upon internal review changes in vision was considered to be an other important medical event.  Additional information is not expected.
Shortly after receiving the booster I developed a headache and nausea  that became more difficult and persisted into the next day. I also had itching - primarily on chest and arms. These symptoms were gone by June 9th.  Also for at least a week following the booster I experienced heavy fatigue - quite unlike a normal feeling of tiredness.
fever, chills, body and headaches, diarrhea, dehydration for 3 days.  Repeat of fever and chills 2 weeks later for 1 day. Pain at injection site 3 weeks later.
Redness and swelling at site evening after injection then the next day fever 102, chills, nausea and vomiting, rash, muscle aches, on 4/27/19-4/28/19 fever and chills resolved but rash progressed in size(erythematous and raised at border, hot and sensitive to touch) Patient being monitored daily started on oral antibiotics on 4/29/19 Augmentin. Rash improving but spreading
The pt developed a temp of 99.4, sleepy but arousalbe. No treatment was given except for Tylenol.
I started experiencing symptoms of a fever in the back of my throat. My father had tested positive the week prior even though he was asymptomatic. Over the next couple of days, I started experiencing body aches, fever and congestion. I tested myself at home and the test came back positive within 30 seconds for COVID-19. I went to the local clinic at a pharmacy and was prescribed PAXLOVID. I slept a lot over the next four days, but on day five of PAXLOVID, I felt a lot better.
Weakness beginning evening of vaccination, unable to get out of bed following morning, slid to floor. Wife reports similar symptoms with previous COVID vaccinations. Patient hospitalized.
Chills the night of, skin very sensitive all over my body, very tired and nauseous, Very dizzy and skin sensitivity the next day. injection sight very swollen , red and painful to touch.
I saw the eye doctor for floaters in June. She mentioned seeing a Retina Specialist if it got worse. In August, I noticed the writing on the TV was distorted when looking out of my right eye with my left eye closed. For a few days, I tried closing my left eye to see if it was resolved, but it wasn't. After a couple of days of driving myself crazy, I went back to the eye doctor. The test they did showed something on the macula. She recommended I see a Retina Specialist. When I went to see him, he told me that it was Branch Retinal Vein Occlusion. He said it can be treated with medication and started treatment that day with an injection in my eye. I go back in a month for another treatment, but I?m not sure how many more treatments I?ll need.
NECK NUMBNESS; NECK SWELLING; POPPING NOISES IN HEAD; FEELING HOT; HEART RACING; CHILLS; HEADACHE; FEVER OF 101.1; DISORIENTED; CONFUSED; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's past medical history included cataracts. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced disoriented. On APR-2021, the subject experienced confused. On APR-2021, the subject experienced fever of 101.1. Laboratory data included: Fever (NR: not provided) 101.1. On 07-APR-2021, the subject experienced neck numbness. On 07-APR-2021, the subject experienced neck swelling. On 07-APR-2021, the subject experienced popping noises in head. On 07-APR-2021, the subject experienced feeling hot. On 07-APR-2021, the subject experienced heart racing. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from neck numbness, neck swelling, heart racing, and chills on 09-APR-2021, and popping noises in head, and feeling hot on APR-2021, and the outcome of headache, fever of 101.1, confused and disoriented was not reported. This report was non-serious.
Breakthrough COVID; Breakthrough COVID; Three strokes; Heart attack; This is a spontaneous report from a contactable consumer (wife who reported for her husband). A male patient of an unspecified age received two doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on Apr2021 (first dose; Lot number was not reported) and on Apr2021 (second dose; Lot number was not reported) both as single doses for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On Jul2021 the patient experienced breakthrough covid, serious due to hospitalization for a week in Jul2021. The patient also experienced three strokes and a heart attack on an unknown date in 2021. Patient was in an assisted living home and there were breakthroughs all the time in there. The final outcome of the events was unknown.The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
When vaccine was injected, the nurse hit a vein or artery, which bled a lot (and HURT!). My upper arm got very black and blue, but on Saturday, it started getting hard and itchy and is now very red and hot, and I have been having diarrhea and nausea and feeling lousy. I plan to call my doctor in the morning and will probably go in for an appointment or go to the hospital to get this checked out.  I took an amoxicillin that I had in the house, because I think it's infected and I wanted to start an antibiotic.
Received COVID-19 Vaccine(Moderna 2nd dose today; Denies adverse reaction with first dose) at approximately 12:45 PM.  Reports had taken prior to vaccination a Claritin and Ibuprofen on advise of PCP. C/0 onset of metallic taste in mouth after vaccine given within <5minutes after vaccination. Placed in close observation area. During assessment  pt reported swallowing difficulty. 911 called via cellphone and placed on speakerphone. Notification of additional staff responding immediately for support.  Epinephrine 1mg/ml given to RD intramuscular. At 1:00PM B/P in right arm was 180/92 and heart rate was 98, at 1:05PM B/P in right arm was 198/88 and heart rate was 97, at 1:05PM, at 1:09 pm O2 sat - 99% HR 103. Ambulance service arrived at 1:20 PM. Report given to EMS. Patient declined to go with EMS. Advised to follow-up with PCP or go for further evaluation at nearest ER. Patient's spouse agreed to take to emergency room and would call Health Department back with update.
Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; This is a spontaneous report from a contactable nurse (patient). A 30-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown unable to locate or read the details) via an unspecified route of administration at Left arm on 23Dec2020 14:15 at single dose covid-19 immunization. Facility type vaccine was Hospital. No known allergies and no other medical history. Concomitant medication included ascorbic acid, calcium pantothenate, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavin, thiamine mononitrate (PRENATAL VITAMINS), colecalciferol (VITAMIN D). No other vaccine in four weeks. The patient experienced itchiness, hives, wilts, abdominal pain on 01Jan2021 23:45. The events resulted in Doctor or other healthcare professional office/clinic visit. No covid prior vaccination and covid was not tested post vaccination. Treatment Benadryl was received for the events. The outcome of the events was recovered in Jan2021.  Information about lot/batch number request.
Patient felt a pressure on arm; Patient felt a ball of hardness like an abscess in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Patient felt a pressure on arm) and VACCINATION SITE INDURATION (Patient felt a ball of hardness like an abscess in the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051H21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 29-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, the patient experienced LIMB DISCOMFORT (Patient felt a pressure on arm) and VACCINATION SITE INDURATION (Patient felt a ball of hardness like an abscess in the injection site). At the time of the report, LIMB DISCOMFORT (Patient felt a pressure on arm) and VACCINATION SITE INDURATION (Patient felt a ball of hardness like an abscess in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient treated with mega garlic for the pain
pt recv vax 3APR97 & 12APR97 pt devel over 100 lesions;
Sunday, January 10, I woke up with a headache and it stayed all day. Later I got a scratchy throat, cough, congested, chilled. Wednesday or Thursday - COVID test - that was negative. Friday night  started having terrible chest pain - heartburn pain -and it went to my last side -I went to ER on January 16 - early morning got to ER - bloodwork was fine, etc. They had me start PEPSID. Cardiac Nurse Practitioner - saw her on January 25th - GI kind of pain - heart was pounding and racing constantly. I have a GI assessment planned - (Ordered by the Cardiac NP). Chills went away on 17th or 18th of January. I have a swollen gland in my neck. I never ran a fever. Temp was always normal. GI assessment will be this Tuesday, the 9th of March.  (I had the second dose of vaccine on January 21.) My heart is still racing a bit. The GI pain is about gone.